The Truth Is Out There

Archive for January, 2026

DARPA Uses AI to Push Viral Pandemic Outbreak Modeling From Weeks to Days


Speed is being prioritized over scrutiny, with AI-generated models designed to justify interventions before they can be meaningfully challenged.

The U.S. military is funding artificial intelligence (AI) systems designed to drastically accelerate viral outbreak modeling—compressing a process that typically takes weeks into something that can be produced in days, then used to steer real-world interventions.

In other words, the faster the model, the less time there is to question whether the response is justified at all.

This acceleration follows DARPA’s already-documented pre-COVID pandemic infrastructure designed to turn digital genetic sequences into synthesized viruses and mass-produced mRNA countermeasures on a fixed timeline.


DARPA’s Stated Problem: Pandemic Models Were Brittle, Opaque, & Slow

According to a December Science publication:

As SARS-CoV-2 radiated across the planet in 2020, epidemiologists scrambled to predict its spread—and its deadly consequences. Often, they turned to models that not only simulate viral transmission and hospitalization rates, but can also predict the effect of interventions: masks, vaccines, or travel bans.

But in addition to being computationally intensive, models in epidemiology and other disciplines can be black boxes: millions of lines of legacy code subject to finicky tunings by operators at research organizations scattered around the world. They don’t always provide clear guidance. “The models that are used are often kind of brittle and nonexplainable,” says Erica Briscoe, who was a program manager for the Automating Scientific Knowledge Extraction and Modeling (ASKEM) project at the Defense Advanced Research Projects Agency (DARPA).

The Defense Advanced Research Projects Agency’s (DARPA) own program manager is conceding that the models used to steer COVID-era responses were fragile and difficult to interpret.

Meaning: they’re not trying to slow down or restrain model-driven policy after COVID.

They’re trying to make the same kind of decision machinery run faster.

There’s “real potential” for them to speed up model building during an outbreak, says Mohsen Malekinejad, an epidemiologist at the University of California San Francisco who helped evaluate the ASKEM products. “In a pandemic, time is always our biggest constraint. We need to have the information. We need to have it fast,” he says. “We simply don’t have enough data-skilled modelers for every single emergence, or every different type of public health need.”

The Program: AI-Generated Outbreak Models on Demand

“Launched in 2022, the $29.4 million program aims to develop artificial intelligence (AI)-based tools that can make model building easier, faster, and more transparent.”

DARPA funded infrastructure that standardizes and accelerates outbreak modeling.

The emphasis is on speed, reproducibility, and usability by non-specialists, allowing policy-relevant models to be generated quickly, even when underlying assumptions are incomplete or contested.

How It Works: Papers & Notebooks → Equations → Models

“The program’s AI tools automate that coding, allowing researchers to construct, update, and combine models at a higher level of abstraction.”

By removing much of the technical friction involved in model construction, these tools make it easier to generate outbreak models that carry institutional weight, even when the scientific grounding is thin or uncertain.

“ASKEM teams designed AI systems that can consume scientific literature… and extract the equations and knowledge needed to create or update a given model.”

Scientific literature is converted directly into reusable model components, giving machine-parsed interpretations of research the ability to propagate quickly into decision-making frameworks.

“One ASKEM project developed a way to ingest those notebooks, extract the underlying mathematical descriptions, and turn them into a model.”

Informal reasoning and exploratory notebook work can be elevated into deployable models at speed, reducing the distance between preliminary thinking and authoritative outputs.

Intervention-Focused Modeling

“The resulting model integrated the viruses’ different transmission and seasonal patterns, while gauging the effects of interventions such as wearing masks and testing.”

The system is designed to evaluate intervention scenarios alongside disease dynamics, embedding policy considerations directly into the modeling process.

“Testers were asked to model the impact of a vaccination campaign on the cost of hospitalization for hepatitis A in a state’s unhoused drug users.”

These tools are oriented toward applied governance questions—cost, targeting, and campaign impact—rather than purely descriptive epidemiology.

The Speed Claim: 83% Faster

“In the final results, testers found that the ASKEM tools, when pitted against standard modeling workflows, could create models 83% faster.”

Model generation is fast enough to fit within political and media timelines, reducing the opportunity for external review before results are acted upon.

“They were able to build practically useful models in a 40-hour work week for multiple problems.”

Once speed ceases to be the limiting factor, the pressure shifts toward rapid implementation rather than careful validation.

‘Transparency’ as an Internal Confidence Signal

“Because of the ASKEM models’ enhanced transparency, testers also found that decision-makers would be more confident in ASKEM’s outputs than in those of traditional models.”

Here, “transparency” functions less as a safeguard and more as a confidence amplifier for officials.

By making models legible enough to satisfy internal review, the system reduces friction within institutions, allowing officials to act more quickly while unresolved uncertainties remain embedded in the outputs.

Intended Users: Health, Defense, & Intelligence Agencies

“DARPA is working to find agencies or programs within the health, defense, and intelligence communities that might want to take advantage of ASKEM.”

Outbreak modeling is being positioned as a permanent national-security capability, integrated alongside defense and intelligence functions rather than treated as an ad hoc public-health exercise.

Bottom Line

DARPA is building a system that converts literature, assumptions, and exploratory analysis into outbreak models fast enough to guide interventions in near real time.

When speed is treated as the primary constraint, the window for scrutiny, dissent, and meaningful challenge necessarily collapses before those models are used to justify action.

Newly U.K.-Approved Self-Replicating COVID Jab ‘Kostaive’ Produces Spike Protein Detectable 28 Days After Vaccination: Journal ‘Biochemistry and Biophysics Reports’


samRNA-copying enzyme also produced in the body post-vaccination detected for at least 15 days, according to study.

Arcturus Therapeutics’s Kostaive (zapomeran, ARCT-154) self-amplifying mRNA COVID-19 vaccine is said to force cells in the body to produce SARS-CoV-2 spike protein—detectable in draining lymph nodes for at least 28 days—and a replicase enzyme that makes more copies of the vaccine mRNA, with the enzyme itself detectable for up to 15 days.

ARCT-154 was quietly approved by U.K. regulators over the weekend.


An April 2025 Biochemistry and Biophysics Reports publication confirms that the ARCT-154 spike protein was “detectable up to 28 days post-vaccination” in mice.

The ARCT-154 samRNA-replicating enzyme also produced in the body post-vaccination was detectable for “up to 15 days.”

The study reads:

The encoded spike protein reached its highest level approximately 3 days after vaccination and quickly disappeared from the rectus femoris muscle, the injection site. Although the spike protein levels also peaked at an early time point in the lymph nodes, it remained detectable 28 days after the vaccination and then disappeared by 44 days after the vaccination. Expression of nsP1, nsP2 and nsP4 was observed in the injected muscle and/or the lymph nodes for up to 15 days post-vaccination.

There were no samples taken at intermediate days like 30, 35, or 40, so we don’t know the exact day the vaccine-produced spike protein became undetectable.

The U.K. press release failed to mention any of this.

Are citizens being fully informed before they consent to this new pharmaceutical injection?

Why are government regulators not providing this information?

Can the Vaccinated Shed samRNA Onto the Unvaccinated?

Exosomes and extracellular vesicles (EVs) are released by cells as part of normal physiology and disease processes, shedding into various bodily fluids such as blood, urine, semen, amniotic fluid, and breast milk.

It is biologically plausible that sa-mRNA, spike protein, and replicase enzymes from Kostaive could be packaged into EVs and exosomes for shedding into bodily fluids—potentially amplified by the self-replicating nature of sa-mRNA—allowing their release into circulation and excretion via blood, sweat, saliva, or breast milk.

A December Science, Public Health Policy, and the Law study shows that spike protein produced by cells from the BioNTech/Pfizer mRNA COVID-19 vaccine is mainly released into the surroundings through extracellular vesicles (which include exosomes).

Moderna knew as early as 2017 that its mRNA vaccine lipid nanoparticles—which carry vaccine mRNA into cells and are used in samRNA jabs—enter the bloodstream and accumulate in the liver, spleen, kidneys, heart, and lungs.

A January 2023 Nature Reviews Drug Discovery paper co-authored by Moderna scientists bluntly admits that avoiding “unacceptable toxicity” in mRNA vaccines remains a major challenge, warning that “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs all present toxicity concerns” and that the way these vaccines spread through the body can cause harm due to “cell tropism and tissue distribution… and their possible reactogenicity.”

Can individuals injected with self-replicating vaccines spread sa-mRNA, spike protein, and replicase enzymes to others?

After those elements are shed onto the unvaccinated, will they become vaccinated?